Shaun Paul Cordoba

Shaun Paul Cordoba is currently the Chief Scientific Officer at JW Therapeutics 药明巨诺. Prior to this role, Shaun served as the Executive Director of Synthetic Biology at Autolus Ltd. where Shaun Paul led a team focused on developing Chimeric Antigen Receptors (CARs) for cancer treatment. Shaun has a strong academic background, having held postdoctoral positions at UCL, Imperial College London, and the University of Oxford. Shaun Paul completed their PhD at the University of Sydney, where Shaun Paul majored in Biochemistry and Immunology.